Session » Abstracts: Patient Outcomes, Preferences, & Attitudes I: Assessment Tools
- 4:00PM-5:30PM
-
Abstract Number: 0825
A Revised Outcome Measure for Dermatomyositis Clinical Trials: The Dermatomyositis Outcomes for Muscle and Skin (DMOMS)
- 4:00PM-5:30PM
-
Abstract Number: 0824
Defining Poor Global Functioning and Health in Axial Spondyloarthritis, Using the EQ-5D-3L Questionnaire, When the ASAS-Health Index Is Not Available Is Feasible. an Analysis of 2651 Patients from the PERSPA Study
- 4:00PM-5:30PM
-
Abstract Number: 0827
Development and Initial Validation of a Brief Measure of Uncertainty in Rheumatic Disease
- 4:00PM-5:30PM
-
Abstract Number: 0826
Development of a Decision Aid for Clinical Trial Participation in Systemic Lupus Erythematosus
- 4:00PM-5:30PM
-
Abstract Number: 0828
Item Reduction and Validation of the Cutaneous Lupus Erythematosus Quality of Life Questionnaire
- 4:00PM-5:30PM
-
Abstract Number: 0823
Sleep Disturbance Predicts Pain Interference in Patients with Early Rheumatoid Arthritis in a Prospective Real-World Cohort